Please assess the completion status of the following clinical trial:

Trial Title: Effect of Renal Impairment on the Pharmacokinetics of NN9535

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent obtained before any trial-related activities. (Trial-related activities are any procedure that would not have been performed during normal management of the subject)~* Subjects meeting the pre-defined GFR (glomerular filtration rate) criteria (estimated by the Cockcroft \& Gault formula) for any of the renal function groups~* Body Mass Index (BMI) equal to or less than 40kg/m2~Exclusion Criteria:~* Known or suspected allergy to trial product(s) or related products~* Renal transplanted patients~* Certain cardiac problems (heart failure, unstable angina, MI (myocardial infarction) within the last 3 months)~* Known current hepatic dysfunction or severe hepatic disease during the last 12 months~* Female of childbearing potential/breast feeding~* History of alcoholism or drug abuse~* Blood donation during the last 8 weeks prior to the study~* Past or current history of pancreatitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).